Literature DB >> 3009680

Oxygen-independent killing by alveolar macrophages.

J R Catterall, S D Sharma, J S Remington.   

Abstract

We have found that normal alveolar macrophages can kill an intracellular parasite by a mechanism that does not involve toxic metabolites of oxygen. We studied the interaction between Toxoplasma gondii and rat alveolar macrophages in vitro. We were interested in Toxoplasma because it causes pneumonia in immunosuppressed patients but not in healthy individuals, and we chose the rat because it resembles immunocompetent human subjects in being resistant to T. gondii. Resident rat alveolar macrophages could kill large numbers of T. gondii. This occurred without a respiratory burst as judged by intracellular reduction of nitroblue tetrazolium and quantitative release of superoxide. Furthermore, scavengers of toxic oxygen metabolites had no effect on the toxoplasmacidal activity of the alveolar macrophages, nor did prior exhaustion of their respiratory burst with PMA. Whereas acid pH (e.g., 4.5-6.0) rapidly kills extracellular T. gondii, raising of the intralysosomal acid pH of rat alveolar macrophages by incubating them with weak bases did not inhibit their ability to kill T. gondii. Killing of Toxoplasma occurred within 1 h of initial exposure to the alveolar macrophages. However, there was no evidence that killing preceded ingestion; Toxoplasma attached to the surface of the cell appeared viable, and when phagocytosis was blocked with sodium fluoride the organisms survived. These results indicate that rat alveolar macrophages possess a powerful nonoxidative microbicidal mechanism, which is distinct from acidification of the phagolysosome but which probably involves phagosome formation. This mechanism may be clinically relevant, for we have recently observed that human alveolar macrophages also kill T. gondii by an oxygen-independent process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009680      PMCID: PMC2188110          DOI: 10.1084/jem.163.5.1113

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

Review 1.  Toxoplasmosis in the adult.

Authors:  J S Remington
Journal:  Bull N Y Acad Med       Date:  1974-02

2.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

3.  Phagosome acidification blocked by intracellular Toxoplasma gondii.

Authors:  L D Sibley; E Weidner; J L Krahenbuhl
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

Review 4.  Mechanisms of macrophage antimicrobial activity.

Authors:  C F Nathan
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

5.  Interaction of primate alveolar macrophages and Legionella pneumophila.

Authors:  R F Jacobs; R M Locksley; C B Wilson; J E Haas; S J Klebanoff
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.

Authors:  H W Murray; R A Gellene; D M Libby; C D Rothermel; B Y Rubin
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

7.  Alveolar macrophage dysfunction in human bone marrow transplant recipients.

Authors:  D J Winston; M C Territo; W G Ho; M J Miller; R P Gale; D W Golde
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

8.  Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.

Authors:  B Poole; S Ohkuma
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

9.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  Macrophage deformability and phagocytosis.

Authors:  M T Mazur; J R Williamson
Journal:  J Cell Biol       Date:  1977-10       Impact factor: 10.539

View more
  13 in total

1.  Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells.

Authors:  V Duquesne; C Auriault; F Darcy; J P Decavel; A Capron
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 2.  Pulmonary macrophages in nosocomial pneumonia: defense function and dysfunction, and prospects for activation.

Authors:  R M Rose
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

3.  Differences in microbicidal activities of human macrophages against Toxoplasma gondii and Trypanosoma cruzi.

Authors:  D M Israelski; F G Araujo; J S Wachtel; L Heinrichs; J S Remington
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages.

Authors:  J R Catterall; C M Black; J P Leventhal; N W Rizk; J S Wachtel; J S Remington
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Trypanosoma cruzi: killing and enhanced uptake by resident peritoneal macrophages treated with alpha-2-macroglobulin.

Authors:  T C Araújo-Jorge; M de N de Meirelles; L Isaac
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection.

Authors:  J Huskinson; P N Stepick-Biek; F G Araujo; P Thulliez; Y Suzuki; J S Remington
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 8.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.

Authors:  K Kagaya; K Watanabe; Y Fukazawa
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Cytotoxic activity of monocytes against Toxoplasma gondii in acute, chronic and reactivated murine toxoplasmosis.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.